Author(s): Lopes, Revelino ; Santos, André ; Gomes, Teresa ; Ribeiro, Júlia ; Rodrigues, Ivone ; Paiva, Bruno ; Nzwalo, Isa ; Catamo Vaz, Deise Haua da Silva ; Baco, Jamal ; Buque, Helena Agostinho ; Botelho, Marta ; Pais, Sandra ; Nzwalo, Hipólito
Date: 2025
Persistent ID: http://hdl.handle.net/10400.1/27465
Origin: Sapientia - Universidade do Algarve
Subject(s): Complex regional pain syndrome; Biomarkers; Cytokines; Neuropeptides; Inflammation; Immune response
Background: Complex regional pain syndrome (CRPS) is a rare, chronic, painful, neurological, debilitating disorder. Despite the substantial impact on quality of life, diagnosis remains challenging due to its complex pathophysiology and subjective clinical criteria. This integrative review aims to synthesize current research on potential diagnostic biomarkers for CRPS. Methods: A systematic search was conducted using the PubMed and Scopus databases to identify relevant studies published until January 2025. Inclusion criteria focused on adult CRPS patients, with studies examining diagnostic or predictive biomarkers. Results: Key findings highlight the role of inflammatory and immune-related biomarkers, such as elevated levels of cytokines (IL-6, TNF-alpha), immune cell infiltration, and specific autoantibodies. Neuropeptides, including substance P and calcitonin gene-related peptide, were associated with pain sensitization in acute phases, though their levels normalized in chronic stages. Additionally, genetic and epigenetic markers, brain imaging, and neurophysiological alterations provided insights into CRPS pathogenesis, emphasizing the dynamic nature of these biomarkers across disease stages. Conclusions: This review underscores the need for further research to integrate these biomarkers into diagnostic frameworks, which could enhance early diagnosis and treatment strategies for CRPS.
